Author: Livozo Editorial. Clinical review: TODO(clinical): reviewer profile pending. See reviewer status. Educational content only; not medical advice.
The core difference
Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on GIP and GLP-1 receptors. A licensed clinician considers medical history, goals, tolerability, availability, and cost.
Safety and fit
Both can cause gastrointestinal effects and have important contraindications. Compounded versions are not FDA-approved and are not generic equivalents of branded medicines.
What to ask
Ask why a specific medication and formulation is being considered, what monitoring is planned, and when symptoms require urgent care.